Methods of treating squamous cell carcinomas with farnesyltransferase inhibitors
US11672774B2 · kind B2 · utility
0Cited by
0References
50Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 28, 2021 |
| Grant date | Jun 13, 2023 |
| Priority date | — |
| Expiry date | Sep 28, 2041 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K2239/38
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to the field of cancer therapy. Specifically, provided are methods of treating Squamous Cell Carcinoma in a subject with a farnesyltransferase inhibitor (FTI) that include determining whether the subject is likely to be responsive to the FTI treatment based on the expression level of H-Ras.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.